Transforming growth factor-s (TGFs) play a prominent role in tumour growth and metastasis by enhancing angiogenesis and suppressing immune surveillance. Despite the increased interest in the effect of TGFs on tumour progression, little is known about the importance of TGF3 and its receptor CD105
Evidence for a positive role of transforming growth factor-β in human breast cancer cell tumorigenesis
✍ Scribed by Carlos L. Arteaga; Teresa C. Dugger; Angela R. Winnier; James T. Forbes
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 527 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
To determine the biological role of transforming growth factor-@ (TGF-@) in mammary carcinomas in vim, estrogen-dependent MCF-7 cells were transfected with a mouse TGF-@I cDNA. Growth characteristics in culture were not altered in the transfected cells. However, the MCF-7/TGF-@1 cells formed tumors in ovariectomized athymic mice in the absence of estrogen supplementation. Daily injections of human recombinant TGF-@I supported tumor formation by wild-type MCF-7 cells in castrated nude mice in the absence of exogenous estradiol. In another approach to the same question, the effect of anti-TGF-@ antibodies on tumor formation by estrogen-independent MDA-231 cells was examined. The 2G7 IgG2b (2G7) antibody, which neutralizes TGF-@I, 42, and 43, blocked the formation of MDA-231 tumors at the injection site and lung metastases in nude mice. Inoculation of MDA-231 cells inhibited, while injection of 2G7 increased mouse spleen natural killer (NK) activity. 2G7 did not inhibit MDA-231 tumors and metastases in NK-deficient animals. Finally, medium conditioned by MDA-231 cells inhibited lymphocyte-mediated NK activity; this inhibition was abrogated by 2G7, but not by a control IgG2. These data support a positive role for tumor cell TGF-@ in the maintenance and/or progression of mammary carcinoma cells in an intact host.
📜 SIMILAR VOLUMES
The progression of breast cancer depends on the establishment of a neovasculature, by a process called angiogenesis. Angiogenesis is an invasive cellular event that requires the co-ordination of numerous molecules including growth factors and their receptors, extracellular proteins, adhesion molecul
At least one member of the TGF-P family, TGF-p1, has been previously shown to inhibit the anchorage-independent growth of some human breast cancer cell lines (Knabbe et al., 1487; Arteaga et al., 1988). Members of the TGF-P family might, [herefore, provide new strategies for breast cancer therapy. W
Cultured human melanoma cells were found to secrete TGF-P mostly in latent biologically inactive form but in addition five of six melanoma cell lines studied produced in conditioned culture medium active TGF-p in the range from 370 to 61 0 pg per 1 O6 cells per 24 h. A distinct characteristic of the
Transforming growth factor-b (TGF-b) plays a central role in a wide array of cellular functions including control of cell growth and differentiation, embryonic development, wound healing, angiogenesis, and immune regulation. In the gastrointestinal tract, TGF-b can either promote or suppress inflamm